Edwards Lifesciences Corporation has announced a management change effective September 1, 2025. Larry L. Wood will resign from his role as Corporate Vice President and Group President of Transcatheter Aortic Valve Replacement and Surgical Structural Heart. Succeeding him will be Daniel J. Lippis, who currently serves as Corporate Vice President for Japan, Greater China, and Asia Pacific.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-164527), on July 25, 2025, and is solely responsible for the information contained therein.